Abstract:During drug development, chromatography is frequently used for purity and stability testing of both drug substance and drug product. Reversed phase liquid chromatography (RPLC) is one of the most widely used methodologies due to its wide scope of application. In the later stages of drug development, the specified impurities and degradation products that define the critical quality attribute of the final API, also known as Key Predictive Sample Set (KPSS), are usually well defined and controlled. At this point, a method review enables selecting the most appropriate technique which should be the one providing optimal robustness (ICH-Q14[1]), with the support of Quality by Design (QbD) approaches. Supercritical Fluid Chromatography (SFC) is a preferred technique for its proven diversity in selectivity. The adoption of a technique which presents the most favourable environmental impact, such as, but not limited to, SFC, is also becoming increasingly important as laboratories strive to reduce carbon footprint. Re-developing a method requires high resource-demands in terms of staff, materials, and time. Any step of the process that can be automated can facilitate this approach, speeding up the delivery of the method whilst preserving robustness. In this article we describe how an SFC method was developed for the purity profiling of a late-stage oncology candidate, taking advantage of the superior selectivity of SFC towards structurally similar analytes, owed to the high orthogonality with R2 as low as 0.014 towards the KPSS. We describe two approaches to automate the method development. Firstly, a multifactorial design of experiments (DoE) and secondly, an optimization via a Bayesian algorithm, which was completed in one night, highlighting the potential and limitations, with an insight into the robustness. Both methods achieved baseline separation with varying levels of automation embedded into the process and a large reduction of the resource demands when compared to traditional optimisation methods. Finally, we describe the beneficial environmental impact that implementing SFC methods can yield, with a calculated green score reduced to a value between 17 and 30 % compared to RPLC, depending on the number of runs per sequence.

Method Development on Automated Sample Preparation System for Cu and Assay Testing in a Product with Multiple Apis and New Strategy for Quick Development and Application

Engineering a Universal and Fully Automatic Analyzer for Multichannel and On-Site Biochemical Detection in Body Fluids

Quality by Design Study of the Direct Analysis in Real Time Mass Spectrometry Response

A Platform Analytical Quality by Design (aqbd) Approach for Multiple Uhplc-Uv and Uhplc-Ms Methods Development for Protein Analysis

Automated multifactorial design of experiment and Bayesian optimisation algorithm approaches to method development for the green analysis by supercritical fluid chromatography of a pharmaceutical ingredient

A Novel Quality by Design Approach for Developing an HPLC Method to Analyze Herbal Extracts: A Case Study of Sugar Content Analysis.

Analytical Quality by Design Oriented Development of the UPLC Method for Analysing Multiple Pharmaceutical Process Intermediates: A Case Study of Compound Danshen Dripping Pills

An improved workflow for the development of MS-compatible liquid chromatography assay purity and purification methods by using automated LC Screening instrumentation and in silico modeling

Improved assay development of pharmaceutical modalities using feedback-controlled liquid chromatography optimization

Rapid Process Development of Chromatographic Process Using Direct Analysis in Real Time Mass Spectrometry As a Process Analytical Technology Tool

Development of a QAMS Analysis Method for Industrial Lanolin Alcohol Based on the Concept of Analytical Quality by Design

Establishment and Validation of the Quantitative Analysis of Multi-Components by Single Marker for the Quality Control of Qishen Yiqi Dripping Pills by High-Performance Liquid Chromatography with Charged Aerosol Detection.

Accelerating attribute‐focused process and product development through the development and deployment of autonomous process analytical technology platform system

Development and Validation of an Automated Liquid Handling System for Sample Preparation Based on Multichannel Air Displacement Pipetting Technology

Using enhanced development tools offered by analytical Quality by Design to support switching of a quality control method

A Simplified and Completely Automated Workflow for Regulated Lc-Ms/Ms Bioanalysis Using Cap-Piercing Direct Sampling and Evaporation-Free Solid Phase Extraction

Automated method development in high-pressure liquid chromatography

A Reliable Automated Sampling System for On-Line and Real-Time Monitoring of CHO Cultures

A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics

Developments in protein assays with flow injection/sequential injection techniques

Targeted CQA analytical control strategy for commercial antibody products: Replacing ion-exchange chromatography methods for charge heterogeneity with multi-attribute monitoring